tiprankstipranks
Trending News
More News >

Adaptive Biotechnologies price target raised to $11 from $7 at Piper Sandler

Piper Sandler raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $11 from $7 following quarterly results. The firm keeps an Overweight rating on the shares.

Don’t Miss TipRanks’ Half Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1